Chris Leavy is a partner with Shire Capital Advisors, where he leads an investment group that has deployed over $100 million into private transactions in the cannabis industry. Chris is currently on the board of Ascend Wellness Holdings and the advisory board of Norcal Cannabis Company. He was named 20 People to Watch by Marijuana Business Magazine and was formerly the Co-Chairman of the Investment Committee for MedMen Opportunity Fund II.
Chris brings over two decades of experience in asset management with senior roles at Morgan Stanley, OppenheimerFunds and BlackRock. As a Managing Director at BlackRock, Chris oversaw $115 billion of fundamental equities and was a member of the firm’s Global Operating Committee. Prior to joining BlackRock, he was the Chief Investment Officer, Equities at OppenheimerFunds (equity assets of $80 billion). Earlier during his tenure at the firm, he built the value equity group from $6 billion to $16 billion of assets and was recognized by Barron’s as a top 100 fund manager. He earned his BA in Economics from Trinity University and his MBA
from Columbia Business School.